14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
Join us for the 12th annual “Selecting Project Delivery Methods & Bidding Public Construction Contr...
Read More >
The United States Supreme Court issued a per curiam opinion on Tuesday in Retirement Plans Committee...
Read More >
Now that January is over and with it many of your New Year’s Resolutions, here is an HR Check List ...
Read More >
Rad and D’Aprile, Inc. v. Arnell Construction Corp, No. 502464/14, 2019 BL 131606 (NY. Sup. Ct. Apr...
Read More >
For a number of ERISA, tax and other regulatory reasons, it may be desirable for the manager or spon...
Read More >
Seyfarth Synopsis: CBD is “thriving” in the current regulatory environment, but is it doing so il...
Read More >